Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.76−0.01 (-0.27%)
Close on Nov 17, 2026Market cap $91.09MP/E –Yield –
Exagen total assets
Total assets on the balance sheet at the end of each period.
Exagen's total assets was $51.94M at Jun 30, 2026. For fiscal 2025 it was $58.02M, up 29.8% from the year before. The highest annual figure on record is $123.45M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.02M | +29.8% |
| FY2024 | Dec 31, 2024 | $44.69M | -21.5% |
| FY2023 | Dec 31, 2023 | $56.94M | -34.0% |
| FY2022 | Dec 31, 2022 | $86.22M | -30.2% |
| FY2021 | Dec 31, 2021 | $123.45M | +57.5% |
| FY2020 | Dec 31, 2020 | $78.38M | -11.3% |
| FY2019 | Dec 31, 2019 | $88.31M | +205.7% |
| FY2018 | Dec 31, 2018 | $28.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $51.94M | -11.6% |
| Q1 FY2026 | Mar 31, 2026 | $51.96M | +28.9% |
| Q4 FY2025 | Dec 31, 2025 | $58.02M | +29.8% |
| Q3 FY2025 | Sep 30, 2025 | $62.82M | +44.1% |
| Q2 FY2025 | Jun 30, 2025 | $58.76M | +19.2% |
| Q1 FY2025 | Mar 31, 2025 | $40.29M | -20.7% |
| Q4 FY2024 | Dec 31, 2024 | $44.69M | -21.5% |
| Q3 FY2024 | Sep 30, 2024 | $43.61M | -28.4% |
| Q2 FY2024 | Jun 30, 2024 | $49.31M | -23.2% |
| Q1 FY2024 | Mar 31, 2024 | $50.81M | -35.9% |
| Q4 FY2023 | Dec 31, 2023 | $56.94M | -34.0% |
| Q3 FY2023 | Sep 30, 2023 | $60.93M | -40.0% |
| Q2 FY2023 | Jun 30, 2023 | $64.18M | -39.9% |
| Q1 FY2023 | Mar 31, 2023 | $79.23M | -35.1% |
| Q4 FY2022 | Dec 31, 2022 | $86.22M | -30.2% |
| Q3 FY2022 | Sep 30, 2022 | $101.60M | -20.5% |
| Q2 FY2022 | Jun 30, 2022 | $106.85M | -19.9% |
| Q1 FY2022 | Mar 31, 2022 | $122.04M | -11.3% |
| Q4 FY2021 | Dec 31, 2021 | $123.45M | +57.5% |
| Q3 FY2021 | Sep 30, 2021 | $127.77M | +59.7% |
| Q2 FY2021 | Jun 30, 2021 | $133.32M | +65.6% |
| Q1 FY2021 | Mar 31, 2021 | $137.52M | +62.5% |
| Q4 FY2020 | Dec 31, 2020 | $78.38M | -11.3% |
| Q3 FY2020 | Sep 30, 2020 | $79.99M | -13.7% |
| Q2 FY2020 | Jun 30, 2020 | $80.51M | +178.7% |
| Q1 FY2020 | Mar 31, 2020 | $84.64M | – |
| Q4 FY2019 | Dec 31, 2019 | $88.31M | – |
| Q3 FY2019 | Sep 30, 2019 | $92.74M | – |
| Q4 FY2018 | Dec 31, 2018 | $28.89M | – |
See a number that looks wrong?